Aptevo Therapeutics Inc. (APVO) Revenue 2016–2023
Aptevo Therapeutics Inc. (APVO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.1MFY2023 · since FY2016: $33.6M → $3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $3.1M | -74.7% |
| FY2022 | $12.3M | +185.3% |
| FY2021 | $4.3M | -86.7% |
| FY2020 | $32.4M | +40.6% |
| FY2019 | $23.1M | +57.4% |
| FY2018 | $14.7M | +46.8% |
| FY2017 | $10.0M | -70.3% |
| FY2016 | $33.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice